These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
233 related items for PubMed ID: 36846574
1. Perspectives of people in Philadelphia who use fentanyl/heroin adulterated with the animal tranquilizer xylazine; Making a case for xylazine test strips. Reed MK, Imperato NS, Bowles JM, Salcedo VJ, Guth A, Rising KL. Drug Alcohol Depend Rep; 2022 Sep; 4():100074. PubMed ID: 36846574 [Abstract] [Full Text] [Related]
5. Xylazine spreads across the US: A growing component of the increasingly synthetic and polysubstance overdose crisis. Friedman J, Montero F, Bourgois P, Wahbi R, Dye D, Goodman-Meza D, Shover C. Drug Alcohol Depend; 2022 Apr 01; 233():109380. PubMed ID: 35247724 [Abstract] [Full Text] [Related]
6. "I probably got a minute": Perceptions of fentanyl test strip use among people who use stimulants. Reed MK, Roth AM, Tabb LP, Groves AK, Lankenau SE. Int J Drug Policy; 2021 Jun 01; 92():103147. PubMed ID: 33583679 [Abstract] [Full Text] [Related]
7. Xylazine in the drug supply: Emerging threats and lessons learned in areas with high levels of adulteration. Quijano T, Crowell J, Eggert K, Clark K, Alexander M, Grau L, Heimer R. Int J Drug Policy; 2023 Oct 01; 120():104154. PubMed ID: 37574646 [Abstract] [Full Text] [Related]
10. Concurrent detection of heroin, fentanyl, and xylazine in seven drug-related deaths reported from the Philadelphia Medical Examiner's Office. Wong SC, Curtis JA, Wingert WE. J Forensic Sci; 2008 Mar 01; 53(2):495-8. PubMed ID: 18284526 [Abstract] [Full Text] [Related]
11. Harm reduction and emergency medical services: Opportunities for evidence-based programming. Friedman NMG, Molina CA, Glenn MJ. Am J Emerg Med; 2023 Oct 01; 72():85-87. PubMed ID: 37499554 [Abstract] [Full Text] [Related]
16. Xylazine Use Among People Who Inject Drugs, Philadelphia 2022. Tan M, Nassau T, Kuncio D, Higgins D, Teixeira da Silva D, Tomlinson D, Brady KA. J Addict Med; 2023 Oct 01; 18(2):194-200. PubMed ID: 38289240 [Abstract] [Full Text] [Related]
17. Potency-Enhancing Synthetics in the Drug Overdose Epidemic: Xylazine ("Tranq"), Fentanyl, Methamphetamine, and the Displacement of Heroin in Philadelphia and Tijuana. Montero F, Bourgois P, Friedman J. J Illicit Econ Dev; 2022 Oct 01; 4(2):204-222. PubMed ID: 37009634 [Abstract] [Full Text] [Related]
18. "Tranq-dope": The first fatal intoxication due to xylazine-adulterated heroin in Italy. Di Trana A, Di Giorgi A, Carlier J, Serra F, Busardò FP, Pichini S. Clin Chim Acta; 2024 Jul 15; 561():119826. PubMed ID: 38909977 [Abstract] [Full Text] [Related]
19. Exploring Xylazine Awareness, Health Impacts, and Harm Reduction Strategies: Findings From a Multimethods Study in Lowell, Massachusetts. Shrestha S, Cyr K, Hajinazarian G, Dillon J, Oh T, Pustz J, Stopka TJ. Subst Use Addctn J; 2024 Aug 03; ():29767342241265181. PubMed ID: 39096153 [Abstract] [Full Text] [Related]
20. Xylazine: A Drug Adulterant of Clinical Concern. Edinoff AN, Sall S, Upshaw WC, Spillers NJ, Vincik LY, De Witt AS, Murnane KS, Kaye AM, Kaye AD. Curr Pain Headache Rep; 2024 May 03; 28(5):417-426. PubMed ID: 38507135 [Abstract] [Full Text] [Related] Page: [Next] [New Search]